A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma.
May 2003 - Oncology; 64(4):0030-2414 [PMID:12759526]
[Westermann AM] [Wiedemann GJ] [Jager E] [Jager D] [Katschinski DM] [Knuth A] [Vörde Sive Vörding PZ] [Van Dijk JD] [Finet J] [Neumann A] [Longo W] [Bakhshandeh A] [Tiggelaar CL] [Gillis W] [Bailey H] [Peters SO] [Robins HI]

Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesothelioma.
Mar 2003 - Lung Cancer; 39(3):0169-5002 [PMID:12609573]
[Bakhshandeh A] [Bruns I] [Traynor A] [Robins HI] [Eberhardt K] [Demedts A] [Kaukel E] [Koschel G] [Gatzemeier U] [Kohlmann T] [Dalhoff K] [Ehlers EM] [Gruber Y] [Zumschlinge R] [Hegewisch-Becker S] [Peters SO] [Wiedemann GJ]

A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermia.
Apr 1999 - Cancer Chemother. Pharmacol.; 43(5):0344-5704 [PMID:10100597]
[Robins HI] [Katschinski DM] [Longo W] [Grosen E] [Wilding G] [Gillis W] [Kraemer C] [Tiggelaar CL] [Rushing D] [Stewart JA] [Spriggs D] [Love R] [Arzoomanian RZ] [Feierabend C] [Alberti D] [Morgan K] [Simon K] [d'Oleire F]

Systemic hyperthermia and ICE chemotherapy for sarcoma patients: rationale and clinical status.
Oct 1997 - Anticancer Res.; 17(4B):0250-7005 [PMID:9329558]
[Wiedemann GJ] [Robins HI] [Katschinski DM] [Mentzel M] [D'Oleire F] [Kutz M] [Wagner T]

Hyperthermic enhancement of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) cytotoxicity in human leukemia cells in vitro.
Oct 1987 - Cancer Res.; 47(16):0008-5472 [PMID:3300964]
[Cohen JD] [Robins HI]

A proposal for the addition of hyperthermia to treatment regimens for acute and chronic leukemia.
Nov 1984 - J. Clin. Oncol.; 2(9):0732-183X [PMID:6381656]
[Robins HI] [Dennis WH] [Steeves RA] [Sondel PM]